Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2429)
All Articles published online
|
Apr 7, 2005 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhu Z, Lin J, Qu JH, Feitelson MA, Ni CR, Li FM, Zhu MH. Inhibitory effect of tumor suppressor p33ING1b and its synergy with p53 gene in hepatocellular carcinoma. World J Gastroenterol 2005; 11(13): 1903-1909 [PMID: 15800978 DOI: 10.3748/wjg.v11.i13.1903] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i13/1903.htm |
| Number | Citing Articles |
| 1 |
Esra Gunduz, Mehmet Gunduz, Levent Bekir Beder, Ryo Tamamura, Hitoshi Nagatsuka, Noriyuki Nagai. Inhibitor of Growth (ING) Family: An Emerging Molecular Target for Cancer Therapy. Journal of Hard Tissue Biology 2008; 17(1): 1 doi: 10.2485/jhtb.17.1
|
| 2 |
Zhi Zhu, Zhigang Luo, Yongmei Li, Canrong Ni, Honghua Li, Minghua Zhu. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Hepatology 2009; 49(2): 504 doi: 10.1002/hep.22675
|
| 3 |
Andrew H. Coles, Stephen N. Jones. The ING gene family in the regulation of cell growth and tumorigenesis. Journal of Cellular Physiology 2009; 218(1): 45 doi: 10.1002/jcp.21583
|
| 4 |
Yifei Lv, Bibek Kumar Purbey, Yanhua Huang, Shuang Li, Gurung Radha, Zhiming Hao. Adenovirus-mediated expression of p33ING1b induces apoptosis and inhibits proliferation in gastric adenocarcinoma cells in vitro. Gastric Cancer 2012; 15(4): 355 doi: 10.1007/s10120-011-0123-4
|
| 5 |
Seyed Mehdi Jafarnejad, Gang Li. Regulation of p53 by ING family members in suppression of tumor initiation and progression. Cancer and Metastasis Reviews 2012; 31(1-2): 55 doi: 10.1007/s10555-011-9329-5
|
| 6 |
Claire Guérillon, Nicolas Bigot, Rémy Pedeux. The ING tumor suppressor genes: Status in human tumors. Cancer Letters 2014; 345(1): 1 doi: 10.1016/j.canlet.2013.11.016
|
| 7 |
Enyu Liu, Jing Wu, Weidong Cao, Jianning Zhang, Weiping Liu, Xiaofan Jiang, Xiang Zhang. Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma. Journal of Neuro-Oncology 2007; 85(3): 263 doi: 10.1007/s11060-007-9421-4
|
| 8 |
Hai-Yan Yang, Hao-Ling Liu, Lan-Tian Tian, Rui-Peng Song, Xuan Song, Da-Long Yin, Ying-Jian Liang, Lian-Dong Qu, Hong-Chi Jiang, Jia-Ren Liu, Lian-Xin Liu. Expression and prognostic value of ING3 in human primary hepatocellular carcinoma. Experimental Biology and Medicine 2012; 237(4): 352 doi: 10.1258/ebm.2011.011346
|
| 9 |
Gesche Tallen, Karl Riabowol. Keep‐ING balance: Tumor suppression by epigenetic regulation. FEBS Letters 2014; 588(16): 2728 doi: 10.1016/j.febslet.2014.03.011
|
| 10 |
Mohsen Esmaeili, Susanne Jennek, Susann Ludwig, Alexandra Klitzsch, Florian Kraft, Christian Melle, Aria Baniahmad. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells. Journal of Molecular Cell Biology 2016; 8(3): 207 doi: 10.1093/jmcb/mjw007
|
| 11 |
Chun‐Ming Wong, Irene O. L. Ng. Molecular pathogenesis of hepatocellular carcinoma. Liver International 2008; 28(2): 160 doi: 10.1111/j.1478-3231.2007.01637.x
|
| 12 |
Hua-kun Zhang, Ke Pan, Hui Wang, De-sheng Weng, Hai-feng Song, Jun Zhou, Wei Huang, Jian-jun Li, Min-shan Chen, Jian-chuan Xia. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma. Cancer Letters 2008; 261(2): 183 doi: 10.1016/j.canlet.2007.11.019
|
| 13 |
Tomoko Tokumaru, Magdeline E. Carrasco Apolinario, Nobuyuki Shimizu, Ryohei Umeda, Koichi Honda, Kenshiro Shikano, Hitoshi Teranishi, Takatoshi Hikida, Toshikatsu Hanada, Keisuke Ohta, Yulong Li, Kazunari Murakami, Reiko Hanada. Hepatic extracellular ATP/adenosine dynamics in zebrafish models of alcoholic and metabolic steatotic liver disease. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-58043-5
|
| 14 |
Damien Ythier, Delphine Larrieu, Christian Brambilla, Elisabeth Brambilla, Rémy Pedeux. The new tumor suppressor genes ING: Genomic structure and status in cancer. International Journal of Cancer 2008; 123(7): 1483 doi: 10.1002/ijc.23790
|
| 15 |
Cheng-long Huang, Hiroyasu Yokomise, Akira Miyatake. Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers. Future Oncology 2007; 3(1): 83 doi: 10.2217/14796694.3.1.83
|
| 16 |
Berna Sayan, Neset Cevdet Tolga Emre, Meliha Burcu Irmak, Mehmet Ozturk, Rengul Cetin-Atalay. Nuclear Exclusion of p33ING1b Tumor Suppressor Protein: Explored in HCC Cells Using a New Highly Specific Antibody. Hybridoma 2009; 28(1): 1 doi: 10.1089/hyb.2008.0058
|
| 17 |
Michael Russell, Philip Berardi, Wei Gong, Karl Riabowol. Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence and apoptosis. Experimental Cell Research 2006; 312(7): 951 doi: 10.1016/j.yexcr.2006.01.020
|
| 18 |
Yoav Gilad, Alicia Oshlack, Gordon K. Smyth, Terence P. Speed, Kevin P. White. Expression profiling in primates reveals a rapid evolution of human transcription factors. Nature 2006; 440(7081): 242 doi: 10.1038/nature04559
|
| 19 |
Juliette Martin, Jean-François Dufour. Tumor suppressor and hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(11): 1720-1733 doi: 10.3748/wjg.14.1720
|